Heron Therapeutics (NASDAQ:HRTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Heron Therapeutics (HRTX) operate in?

Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Heron Therapeutics Stock (NASDAQ: HRTX) stock price, news, charts, stock research, profile.

Open	$1.14
Close	$1.19
Volume / Avg.	2.14M / 1.81M
Day Range	$1.11 - $1.21
52 Wk Range	0.87 - 3.93
Market Cap	$182.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	24
Short Interest	24.47%
Days to Cover	20.25

Recent News

Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

FDA Expands Argenx's Vyvgart Label to Treat Rare Disorder

Shares of Argenx (NASDAQ: ARGX) rose nearly 4% on Friday after management announced that the FDA approved its subcutaneously administered Vyvgart Hytrulo (efgartigimod) for a second indication — chronic inflammatory demyelinating polyneuropathy (CIDP).

Zacks

Avidity Up 33% on Rare Muscle Disease Study Results

Avidity Biosciences (NASDAQ: RNA) announced encouraging initial data from the phase I/II FORTITUDE study evaluating two doses of delpacibart braxlosiran (del-brax, or formerly AOC 1020) in facioscapulohumeral muscular dystrophy (FSHD), a rare genetic disease of the muscles.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.14
Close	$1.19
Volume / Avg.	2.14M / 1.81M
Day Range	$1.11 - $1.21
52 Wk Range	0.87 - 3.93
Market Cap	$182.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	24
Short Interest	24.47%
Days to Cover	20.25

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Heron Therapeutics (HRTX) stock?

You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.

View our list of the best stock brokerages

Who are Heron Therapeutics (HRTX) competitors?

Other companies in Heron Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Atossa Therapeutics (NASDAQ:ATOS), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).

What is the forecast, or price target, for Heron Therapeutics (HRTX) stock?

Heron Therapeutics has a consensus price target of $6.75.

What is the current price for Heron Therapeutics (HRTX)?

The stock price for Heron Therapeutics (NASDAQ: HRTX) is $1.2 last updated November 19, 2024 at 4:11 PM EST.

Does Heron Therapeutics (HRTX) pay a dividend?

There are no upcoming dividends for Heron Therapeutics.

When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?

Heron Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Heron Therapeutics (HRTX) going to split?

There is no upcoming split for Heron Therapeutics.

What sector and industry does Heron Therapeutics (HRTX) operate in?

Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Heron Therapeutics

Heron Therapeutics (HRTX) Forecast